Oct. 2, 2025

The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) Imaging Network, managed by the ACR Center for Research and Innovation, offers participating imaging facilities exclusive access to discounted FDA-cleared AI tools and data visualization resources— to enhance Alzheimer’s imaging workflows and patient safety.

With 41 imaging facilities already participating, another 72 in start-up, and 3,184 patients enrolled from 115 referring dementia practices nationwide, ALZ-NET supports real-world evidence generation to inform FDA safety assessments and clinical guidelines – including appropriate PET use and MR safety.

Imaging facilities are invited to contribute longitudinal brain imaging data from patients receiving FDA-approved Alzheimer’s treatments.

Join the ALZ-NET Interest List today.

Related ACR News

  • ACR Attends 2025 RUC Meetings

    ACR participated in the American Medical Association/Specialty Society RVS Update Committee meeting where they heard updates on the AMA Physician Practice Information Survey.

    Read more
  • NCI Releases FY 2027 Budget Proposal

    Anthony Letai, MD, PhD, became NCI Director Sept. 29, leading with a $7.2B budget and proposing $11.5B for FY 2027 to boost cancer research.

    Read more
  • ACR Participates in Strategic Radiology Fall Summit

    ACR joined the Strategic Radiology Fall Summit, sharing updates on advocacy, policy, workforce, economics, and AI in radiology.

    Read more